WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
US5714465A
(en)
|
1989-05-19 |
1998-02-03 |
Amgen Inc. |
Method of inhibiting tumor cell dissemination with a metalloproteinase inhibitor
|
US7144731B2
(en)
|
1989-10-16 |
2006-12-05 |
Amgen Inc. |
SCF antibody compositions and methods of using the same
|
US5574138A
(en)
|
1993-03-08 |
1996-11-12 |
Immunex Corporation |
Epithelium-derived T-cell factor
|
US7138500B1
(en)
|
1993-05-07 |
2006-11-21 |
Immunex Corporation |
Antibodies to human 4-1BB
|
US7211259B1
(en)
|
1993-05-07 |
2007-05-01 |
Immunex Corporation |
4-1BB polypeptides and DNA encoding 4-1BB polypeptides
|
US6630143B1
(en)
|
1993-05-24 |
2003-10-07 |
Immunex Corporation |
Antibodies against flt3 ligand
|
US7045128B2
(en)
|
1993-05-24 |
2006-05-16 |
Immunex Corporation |
Antibodies against flt3-ligand
|
US6303769B1
(en)
|
1994-07-08 |
2001-10-16 |
Immunex Corporation |
Lerk-5 dna
|
US5885574A
(en)
|
1994-07-26 |
1999-03-23 |
Amgen Inc. |
Antibodies which activate an erythropoietin receptor
|
US5919905A
(en)
|
1994-10-05 |
1999-07-06 |
Immunex Corporation |
Cytokine designated LERK-6
|
US6406901B1
(en)
|
1995-06-08 |
2002-06-18 |
Immunex Corporation |
TNF-a converting enzyme
|
AU720232B2
(en)
|
1996-07-19 |
2000-05-25 |
Amgen, Inc. |
Analogs of cationic proteins
|
JP2002509431A
(ja)
|
1996-12-23 |
2002-03-26 |
イミュネックス・コーポレーション |
NF−κBのレセプター活性化因子−レセプターはTNFレセプタースーパーファミリーの一員である−
|
US5741772A
(en)
|
1997-02-03 |
1998-04-21 |
Amgen Inc. |
Neurotrophic factor NNT-1
|
US6316408B1
(en)
|
1997-04-16 |
2001-11-13 |
Amgen Inc. |
Methods of use for osetoprotegerin binding protein receptors
|
EP1717315A3
(en)
|
1997-04-16 |
2007-06-20 |
Amgen Inc. |
Osteoprotegerin binding proteins and receptors
|
US20020173629A1
(en)
|
1997-05-05 |
2002-11-21 |
Aya Jakobovits |
Human monoclonal antibodies to epidermal growth factor receptor
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
AU742757C
(en)
|
1997-12-17 |
2007-05-17 |
Immunex Corporation |
Cell surface glycoproteins associated with human B cell lymphomas - ULBP, DNA and polypeptides
|
CA2316034A1
(en)
|
1997-12-23 |
1999-07-01 |
Immunex Corporation |
Sigirr dna and polypeptides
|
EP1043335A4
(en)
|
1997-12-25 |
2005-08-31 |
Japan Tobacco Inc |
MONOCLONAL ANTIBODY AGAINST CONNECTIVE TISSUE GROWTH FACTOR AND ITS MEDICAL APPLICATIONS
|
NZ505499A
(en)
|
1998-01-23 |
2002-07-26 |
Immunex Corp |
Accessory protein-like DNA and polypeptides
|
ES2315016T3
(es)
|
1998-08-07 |
2009-03-16 |
Immunex Corporation |
Moleculas llamadas b7l-1.
|
EP1102848B1
(en)
|
1998-08-07 |
2010-10-13 |
Immunex Corporation |
Molecules designated ldcam
|
ATE362534T2
(de)
|
1998-11-13 |
2007-06-15 |
Immunex Corp |
Menschliche tslp nukleinsäuren und polypeptide
|
US6682736B1
(en)
|
1998-12-23 |
2004-01-27 |
Abgenix, Inc. |
Human monoclonal antibodies to CTLA-4
|
US7109003B2
(en)
|
1998-12-23 |
2006-09-19 |
Abgenix, Inc. |
Methods for expressing and recovering human monoclonal antibodies to CTLA-4
|
US7435796B1
(en)
|
1999-02-03 |
2008-10-14 |
Amgen Inc. |
Antibodies which bind B7RP1
|
ES2571230T3
(es)
|
1999-04-09 |
2016-05-24 |
Kyowa Hakko Kirin Co Ltd |
Procedimiento para controlar la actividad de una molécula inmunofuncional
|
US7459540B1
(en)
|
1999-09-07 |
2008-12-02 |
Amgen Inc. |
Fibroblast growth factor-like polypeptides
|
JP2001206899A
(ja)
|
1999-11-18 |
2001-07-31 |
Japan Tobacco Inc |
TGF−βII型受容体に対するヒトモノクローナル抗体及びその医薬用途
|
US20030103978A1
(en)
|
2000-02-23 |
2003-06-05 |
Amgen Inc. |
Selective binding agents of osteoprotegerin binding protein
|
DK2990420T3
(en)
|
2000-05-26 |
2017-04-03 |
Immunex Corp |
USE OF INTERLEUKIN-4 RECEPTOR ANTIBODIES AND COMPOSITIONS THEREOF
|
EP1317536B1
(en)
|
2000-09-05 |
2009-05-13 |
Amgen Inc. |
Tnf receptor-like molecules and uses thereof
|
BRPI0116728B1
(pt)
|
2001-01-05 |
2018-10-30 |
Abgenix Inc |
anticorpos para receptor de fator de crescimento i semelhante à insulina
|
AU2002356511A1
(en)
|
2001-07-30 |
2003-04-01 |
Immunex Corporation |
T. reesei phytase enyzmes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using
|
US7084257B2
(en)
|
2001-10-05 |
2006-08-01 |
Amgen Inc. |
Fully human antibody Fab fragments with human interferon-gamma neutralizing activity
|
US7658924B2
(en)
|
2001-10-11 |
2010-02-09 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
US7521053B2
(en)
|
2001-10-11 |
2009-04-21 |
Amgen Inc. |
Angiopoietin-2 specific binding agents
|
CA2464239C
(en)
|
2001-10-23 |
2016-07-12 |
Psma Development Company, L.L.C. |
Psma antibodies and protein multimers
|
AR039067A1
(es)
|
2001-11-09 |
2005-02-09 |
Pfizer Prod Inc |
Anticuerpos para cd40
|
AU2002351204B2
(en)
|
2001-12-03 |
2008-07-10 |
Abgenix, Inc. |
Anti-CD45RB antibodies for use in treating autoimmune disease and transplant rejection
|
JP2005538682A
(ja)
|
2001-12-03 |
2005-12-22 |
アブジェニックス・インコーポレーテッド |
カルボキシックアンヒドラーゼix(caix)腫瘍抗原に対する抗体
|
JP2005516965A
(ja)
|
2001-12-28 |
2005-06-09 |
アブジェニックス・インコーポレーテッド |
抗muc18抗体を使用する方法
|
DE60226499D1
(de)
|
2001-12-28 |
2008-06-19 |
Amgen Fremont Inc |
Verwendung von antikörpern gegen das muc18-antigen
|
ES2289174T3
(es)
|
2001-12-28 |
2008-02-01 |
Amgen Fremont Inc. |
Anticuerpos contra el antigeno muc-18.
|
US7135174B2
(en)
|
2002-01-07 |
2006-11-14 |
Amgen Fremont, Inc. |
Antibodies directed to PDGFD and uses thereof
|
CN1326879C
(zh)
|
2002-03-29 |
2007-07-18 |
先灵公司 |
人源抗白细胞介素5单克隆抗体及其制备方法和包含这些抗体的组合物
|
EP1494714A4
(en)
|
2002-04-05 |
2008-03-05 |
Amgen Inc |
HUMAN ANTI-OPGL NEUTRALIZING ANTIBODIES AS SELECTIVE OPGL PATH HEMMER
|
CA2496419A1
(en)
|
2002-08-19 |
2004-02-26 |
Abgenix, Inc. |
Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof
|
DK1572946T3
(da)
|
2002-09-06 |
2012-07-02 |
Amgen Inc |
Terapeutisk humant monoklonalt anti-IL-1R1-antistof
|
US7335743B2
(en)
|
2002-10-16 |
2008-02-26 |
Amgen Inc. |
Human anti-IFN-γ neutralizing antibodies as selective IFN-γ pathway inhibitors
|
ES2347239T3
(es)
|
2002-12-02 |
2010-10-27 |
Amgen Fremont Inc. |
Anticuerpos dirigidos al factor de necrosis tumoral y usos de los mismos.
|
EP1639092B1
(en)
|
2003-06-27 |
2016-01-06 |
Amgen Fremont Inc. |
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
|
MXPA06000583A
(es)
|
2003-07-15 |
2006-03-30 |
Amgen Inc |
Anticuerpos neutralizantes anti-ngf humano como inhibidores selectivos de la via del ngf.
|
WO2005012530A2
(en)
|
2003-07-25 |
2005-02-10 |
Amgen Inc. |
Antagonists and agonists of ldcam and methods of use
|
HN2004000285A
(es)
|
2003-08-04 |
2006-04-27 |
Pfizer Prod Inc |
ANTICUERPOS DIRIGIDOS A c-MET
|
AU2003282780A1
(en)
|
2003-08-08 |
2005-03-07 |
Abgenix, Inc. |
Antibodies directed to parathyroid hormone (pth) and uses thereof
|
US7318925B2
(en)
|
2003-08-08 |
2008-01-15 |
Amgen Fremont, Inc. |
Methods of use for antibodies against parathyroid hormone
|
AR045563A1
(es)
|
2003-09-10 |
2005-11-02 |
Warner Lambert Co |
Anticuerpos dirigidos a m-csf
|
EP1692184B1
(en)
|
2003-11-07 |
2012-03-07 |
Immunex Corporation |
Antibodies that bind interleukin-4 receptor
|
US7371381B2
(en)
|
2003-12-12 |
2008-05-13 |
Amgen Inc. |
Anti-galanin antibodies and uses thereof
|
PE20051053A1
(es)
|
2004-01-09 |
2005-12-12 |
Pfizer |
ANTICUERPOS CONTRA MAdCAM
|
KR20070007884A
(ko)
|
2004-04-23 |
2007-01-16 |
암젠 인크 |
Cd148의 혈관신생 억제 도메인의 항체
|
US20050287140A1
(en)
|
2004-04-23 |
2005-12-29 |
Amgen Inc. |
Antibodies to angiogenesis inhibiting domains of CD148
|
CA2574881C
(en)
|
2004-08-04 |
2013-01-08 |
Amgen Inc. |
Antibodies to dkk-1
|
US7423128B2
(en)
|
2004-11-03 |
2008-09-09 |
Amgen Fremont Inc. |
Anti-properdin antibodies, and methods for making and using same
|
WO2006055638A2
(en)
|
2004-11-17 |
2006-05-26 |
Abgenix, Inc. |
Fully human monoclonal antibodies to il-13
|
MY146381A
(en)
|
2004-12-22 |
2012-08-15 |
Amgen Inc |
Compositions and methods relating relating to anti-igf-1 receptor antibodies
|
EP1841455A1
(en)
|
2005-01-24 |
2007-10-10 |
Amgen Inc. |
Humanized anti-amyloid antibody
|
EP1851245B1
(en)
|
2005-01-26 |
2012-10-10 |
Amgen Fremont Inc. |
Antibodies against interleukin-1 beta
|
WO2006104677A2
(en)
|
2005-03-24 |
2006-10-05 |
Millennium Pharmaceuticals, Inc. |
Antibodies that bind ov064 and methods of use therefor
|
US7807159B2
(en)
|
2005-04-25 |
2010-10-05 |
Amgen Fremont Inc. |
Antibodies to myostatin
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
EP2388277A3
(en)
|
2005-07-18 |
2013-03-20 |
Amgen, Inc |
Human anti-B7RP1 neutralizing antibodies
|
PE20071101A1
(es)
|
2005-08-31 |
2007-12-21 |
Amgen Inc |
Polipeptidos y anticuerpos
|
ES2546069T3
(es)
|
2005-09-07 |
2015-09-18 |
Amgen Fremont Inc. |
Anticuerpos monoclonales humanos para quinasa-1 de tipo receptor de activina (ALK-1)
|
RS52357B
(en)
|
2005-12-13 |
2012-12-31 |
Medimmune Limited |
BINDING PROTEINS SPECIFIC TO INSULIN SIMILAR GROWTH FACTORS AND THEIR USE
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
US7888482B2
(en)
|
2006-02-10 |
2011-02-15 |
Amgen Inc. |
Antibodies that bind PAR-2
|
TWI395754B
(zh)
|
2006-04-24 |
2013-05-11 |
Amgen Inc |
人類化之c-kit抗體
|
WO2008060331A2
(en)
|
2006-05-19 |
2008-05-22 |
Amgen Inc. |
Antibodies to sars coronavirus
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
CL2007002668A1
(es)
|
2006-09-20 |
2008-05-09 |
Amgen Inc |
Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2.
|
US7833527B2
(en)
|
2006-10-02 |
2010-11-16 |
Amgen Inc. |
Methods of treating psoriasis using IL-17 Receptor A antibodies
|
GT200800034A
(es)
|
2007-04-02 |
2010-03-16 |
|
Anticuerpos anti-ige
|
CL2008001887A1
(es)
|
2007-06-29 |
2008-10-03 |
Amgen Inc |
Proteinas de union a antigeno que se unen al receptor activado por proteasas 2 (par-2); acido nucleico que las codifica; vector y celula huesped; metodo de produccion; y composicion que las comprende.
|
WO2009009086A2
(en)
|
2007-07-12 |
2009-01-15 |
Sangamo Biosciences, Inc. |
Methods and compositions for inactivating alpha 1,6 fucosyltransferase (fut 8) gene expression
|
CL2008002153A1
(es)
|
2007-07-24 |
2009-06-05 |
Amgen Inc |
Anticuerpo aislado o fragmanto de unión de antigeno del mismo que se une al receptor de il-18 (il-18r); molecula de ácido nucleico codificante; celula huesped que la comprende; composición farmaceutica; uso médico para tratar o prevenir una condición asociada con il-18r; método in vitro para inhibir la unión de il-18 al il-18r.
|
CL2008002444A1
(es)
|
2007-08-21 |
2009-09-04 |
Amgen Inc |
Anticuerpo o fragmento del mismo que se une a la proteina c-fms humana; molecula de acido nucleico que la codifica; vector y celula huesped; metodo de elaboracion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir una condicion asociada con c-fms en un paciente.
|
JOP20080381B1
(ar)
|
2007-08-23 |
2023-03-28 |
Amgen Inc |
بروتينات مرتبطة بمولدات مضادات تتفاعل مع بروبروتين كونفيرتاز سيتيليزين ككسين من النوع 9 (pcsk9)
|
US7982016B2
(en)
|
2007-09-10 |
2011-07-19 |
Amgen Inc. |
Antigen binding proteins capable of binding thymic stromal lymphopoietin
|
EP2235058A2
(en)
|
2007-12-21 |
2010-10-06 |
Amgen, Inc |
Anti-amyloid antibodies and uses thereof
|
JO2913B1
(en)
|
2008-02-20 |
2015-09-15 |
امجين إنك, |
Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
|
JP2011519279A
(ja)
|
2008-05-01 |
2011-07-07 |
アムジエン・インコーポレーテツド |
抗ヘプシジン抗体及び使用の方法
|
WO2010107752A2
(en)
|
2009-03-20 |
2010-09-23 |
Amgen Inc. |
Alpha-4-beta-7 heterodimer specific antagonist antibody
|
DK2438171T3
(en)
|
2009-06-02 |
2015-01-26 |
Regeneron Pharma |
Fucosylerings-deficient cells
|
CA2773240C
(en)
|
2009-09-22 |
2015-11-10 |
Volker Sandig |
Process for producing molecules containing specialized glycan structures
|
AU2010303415B2
(en)
|
2009-10-07 |
2015-02-19 |
Macrogenics, Inc. |
Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
US9504702B2
(en)
|
2010-08-05 |
2016-11-29 |
Seattle Genetics, Inc. |
Methods of inhibition of protein fucosylation in vivo using fucose analogs
|
CA2862925C
(en)
*
|
2012-02-10 |
2020-01-21 |
University Of Maryland, Baltimore |
Chemoenzymatic glycoengineering of antibodies and fc fragments thereof
|
US20160237399A1
(en)
|
2015-02-18 |
2016-08-18 |
Biogen Ma Inc. |
Control of Protein Glycosylation by Culture Medium Supplementation and Cell Culture Process Parameters
|
TWI682033B
(zh)
|
2014-03-17 |
2020-01-11 |
泉盛生物科技股份有限公司 |
製造具有經修飾的糖苷化作用之重組糖蛋白之方法
|
EP3149045B1
(en)
*
|
2014-05-27 |
2023-01-18 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
US10077434B2
(en)
|
2014-07-30 |
2018-09-18 |
Zumutor Biologics Inc. |
Non-fucosylated protein and methods thereof
|
ES2712303T3
(es)
|
2014-11-15 |
2019-05-10 |
Zumutor Biologics Inc |
Dominio de unión a ADN del sistema CRISPR para la producción de proteínas no fucosiladas y parcialmente fucosiladas
|
SG11201704351WA
(en)
|
2014-12-01 |
2017-06-29 |
Amgen Inc |
Process for manipulating the level of glycan content of a glycoprotein
|
US11267899B2
(en)
|
2015-05-13 |
2022-03-08 |
Zumutor Biologics Inc. |
Afucosylated protein, cell expressing said protein and associated methods
|
MX2018004831A
(es)
|
2015-11-02 |
2018-08-01 |
Genentech Inc |
Metodos para confeccionar formas fucosiladas y afucosiladas de una proteina.
|
WO2018031734A1
(en)
*
|
2016-08-10 |
2018-02-15 |
University Of Maryland, College Park |
DESIGNER α1,6-FUCOSIDASE MUTANTS ENABLE DIRECT CORE FUCOSYLATION OF INTACT N-GLYCOPEPTIDES AND N-GLYCOPROTEINS
|
CA3034876C
(en)
|
2016-08-24 |
2022-10-04 |
CHO Pharma Inc. |
Endoglycosidase mutants for glycoprotein remodeling and methods of using it
|
EP3339444A1
(en)
|
2016-12-20 |
2018-06-27 |
Mabxience Research, S.L. |
Method for obtaining a glycoprotein with an increased percentage of afucosylated glycans
|
JP2020513813A
(ja)
|
2017-03-14 |
2020-05-21 |
アムジエン・インコーポレーテツド |
細胞培養において産生される抗体の総非フコシル化グリコフォームの調節
|
US10260056B2
(en)
*
|
2017-03-17 |
2019-04-16 |
New England Biolabs, Inc. |
Cleavage of fucose in N-glycans
|
CN107881160A
(zh)
|
2017-08-11 |
2018-04-06 |
百奥泰生物科技(广州)有限公司 |
一种由基因组被编辑的cho宿主细胞产生的具有独特糖谱的重组抗体及其制备方法
|
JP2021519068A
(ja)
|
2018-03-26 |
2021-08-10 |
アムジェン インコーポレイテッド |
細胞培養において産生される抗体の総非フコシル化グリコフォーム
|
CN110373374B
(zh)
|
2018-04-12 |
2023-07-07 |
上海颢哲信息科技有限公司 |
一种降低抗体核心岩藻糖基化的方法和组合物
|
WO2019224333A1
(en)
|
2018-05-24 |
2019-11-28 |
Ares Trading S.A. |
Method for controlling the afucosylation level of a glycoprotein composition
|
US20210115413A1
(en)
|
2018-06-20 |
2021-04-22 |
Massachusetts Institute Of Technology |
Methods of glycoengineering proteoglycans with distinct glycan structures
|
SG11202100756RA
(en)
|
2018-08-10 |
2021-02-25 |
Genentech Inc |
Cell culture strategies for modulating protein glycosylation
|
CN113166728A
(zh)
|
2018-08-29 |
2021-07-23 |
联合生物制药股份有限公司 |
去岩藻醣基化抗体及其制造
|
AU2018438163A1
(en)
|
2018-08-29 |
2021-04-01 |
United Biopharma Inc |
Afucosylated antibodies and manufacture thereof
|
HU231514B1
(hu)
|
2018-11-07 |
2024-07-28 |
Richter Gedeon Nyrt. |
Sejttenyészetben előállított rekombináns glikoprotein glikozilációs mintázatának megváltoztatására szolgáló módszer
|
CN114026229A
(zh)
*
|
2019-08-05 |
2022-02-08 |
醣基生医股份有限公司 |
用于重塑抗体醣型之融合蛋白
|